Last reviewed · How we verify
Marjan Industria e Comercio ltda — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
1 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Valeriana | Valeriana | marketed | Standardized Chemical Allergen [EPC] | Other | ||
| Passiflora ; Crataegus and Salix | Passiflora ; Crataegus and Salix | phase 3 | Herbal combination / Phytotherapeutic agent | Cardiovascular / Anxiolytic |
Therapeutic area mix
- Cardiovascular / Anxiolytic · 1
- Other · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- · 1 shared drug class
- Bionorica SE · 1 shared drug class
- Deseret Biologicals, Inc. · 1 shared drug class
- Donat R. Spahn · 1 shared drug class
- Dr. Laurence Klotz · 1 shared drug class
- Millet Roux · 1 shared drug class
- Nantes University Hospital · 1 shared drug class
- Nutritional Specialties, Inc. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Marjan Industria e Comercio ltda:
- Marjan Industria e Comercio ltda pipeline updates — RSS
- Marjan Industria e Comercio ltda pipeline updates — Atom
- Marjan Industria e Comercio ltda pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Marjan Industria e Comercio ltda — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/marjan-industria-e-comercio-ltda. Accessed 2026-05-15.